Clinical Trial Update: Neoadjuvant Chemotherapy + PD-1 Inhibitor+Different Radiotherapy Fractionations for HR+/HER2- Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating neoadjuvant chemotherapy plus a PD-1 inhibitor and different radiotherapy fractionations in HR+/HER2- breast cancer. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Lei Liu | Conditions: HR+HER2- Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING